abstract |
Compounds, compositions and methods are provided for modulating glucagon receptor expression. The composition comprises an antisense compound, in particular an antisense oligonucleotide, having specific in vivo properties targeted to a nucleic acid encoding a glucagon receptor. Methods of using these compounds are provided for modulation of glucagon receptor expression and for treatment of diseases. |